 
  China Approves First Domestic 9-Valent HPV Vaccine
China’s drug regulator approves the country’s first domestically developed 9-valent HPV vaccine, targeting nine strains to boost protection against cervical cancer.
My Global News: Voices of a New Era
๐ Stay Ahead, Stay Global ๐
 
  China’s drug regulator approves the country’s first domestically developed 9-valent HPV vaccine, targeting nine strains to boost protection against cervical cancer.
 
  The Chinese mainland greenlights Cecolin 9, its first domestically developed nine-valent HPV vaccine, promising over 98% protection and an easier two-dose schedule for teens.
 
  Jing’an County rolls out free HPV vaccines for schoolgirls as part of national effort to eliminate cervical cancer, backed by health experts and policymakers.